gemtuzumab ozogamicin

Inotuzumab Ozogamicin

Products Inotuzumab ozogamicin was approved in many countries, in the EU, and in the United States in 2017 as a powder for a concentrate for the preparation of an infusion solution (Besponsa). See also under gemtuzumab ozogamicin. Structure and properties Inotuzumab ozogamicin is an antibody-drug conjugate directed against CD22. Inotuzumab is a humanized lgG4 monoclonal … Inotuzumab Ozogamicin

Gemtuzumab Ozogamicin

Products Gemtuzumab ozogamicin is approved as a powder for a concentrate for the preparation of an infusion solution (Mylotarg). It was approved in the United States in 2017, in the EU in 2018, and in many countries in 2019 It was previously marketed in the United States between 2000 and 2010 but was withdrawn from … Gemtuzumab Ozogamicin